First large Canadain Psychedelic Survey sponsored by MAPS PBC, Psygen, and SABI Mind, in collaboration with academics from Johns Hopkins, UCLA, University of Alabama, University of Michigan, Cleveland Clinic, McMaster, McGill, and UBC.
On January 5, 2022, Health Canada made a historic amendment to its drug laws to allow restricted drugs, such as MDMA and Psilocybin, to be accessible, under special conditions, through the Special Access Program.
Since MDMA Therapy is essentially healing-with-love, to end 2021 on a total love note, I would like to share with you a 6-minute interview Rick did with Sara Rose Siskind that will likely make your heart grow.
The question I asked was, “What happens when hippies are armed with a legal pharma company?” The answers I found made my heart grow.
In this blog, I would like to share with you a brief newscast just aired on NBC TODAY Show
Breaking News: MAPS therapists-in-training might be able to experience an MDMA dosing session first-hand
After two years of negotiations, MAPS won an appeal with the FDA to pave the way for future therapists-in-training to experience an MDMA dosing session first-hand.
The Multidisciplinary Association for Psychedelic Studies just published their largest-to-date study on the effectiveness and safety of MDMA-Assisted Therapy for PTSD*, and the results are, well, somewhat earth shattering.
Imagine 35 years ago. Just as the FDA is about to place the love drug MDMA on Schedule 1 (Totally bad!!! Totally illegal!!!), Rick Doblin, whose heart grew a few sizes too big (I imagine partially because of MDMA), decides that the way to bring MDMA to therapy is not through underground practices but through legal means.
This is the news many people have been waiting for: MAPS Public Benefit Corporation has now opened the applications for MDMA-Assisted Therapy training outside the research context!
Johns Hopkins Center for Psychedelic and Consciousness Research just published a well designed study showing that Psilocybin is effective in treating depression.